Continuous positive airway pressure for motion management in stereotactic body radiation therapy to the lung: A controlled pilot study earlier versions of this work were accepted for presentation at the third ESTRO Forum, April 24-28, 2015, in Barcelona, Spain, and ISCORT, January 27-30, 2015, in Eilat, Israel.

Jeffrey D. Goldstein, Yaacov R. Lawrence, Sarit Appel, Efrat Landau, Merav A. Ben-David, Tatiana Rabin, Maoz Benayun, Sergey Dubinski, Noam Weizman, Dror Alezra, Hila Gnessin, Adam M. Goldstein, Khader Baidun, Michael J. Segel, Nir Peled, Zvi Symon

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Objective To determine the effect of continuous positive airway pressure (CPAP) on tumor motion, lung volume, and dose to critical organs in patients receiving stereotactic body radiation therapy (SBRT) for lung tumors. Methods and Materials After institutional review board approval in December 2013, patients with primary or secondary lung tumors referred for SBRT underwent 4-dimensional computed tomographic simulation twice: with free breathing and with CPAP. Tumor excursion was calculated by subtracting the vector of the greatest dimension of the gross tumor volume (GTV) from the internal target volume (ITV). Volumetric and dosimetric determinations were compared with the Wilcoxon signed-rank test. CPAP was used during treatment if judged beneficial. Results CPAP was tolerated well in 10 of the 11 patients enrolled. Ten patients with 18 lesions were evaluated. The use of CPAP decreased tumor excursion by 0.5 ± 0.8 cm, 0.4 ± 0.7 cm, and 0.6 ± 0.8 cm in the superior-inferior, right-left, and anterior-posterior planes, respectively (P≤.02). Relative to free breathing, the mean ITV reduction was 27% (95% confidence interval [CI] 16%-39%, P<.001). CPAP significantly augmented lung volume, with a mean absolute increase of 915 ± 432 cm and a relative increase of 32% (95% CI 21%-42%, P=.003), contributing to a 22% relative reduction (95% CI 13%-32%, P=.001) in mean lung dose. The use of CPAP was also associated with a relative reduction in mean heart dose by 29% (95% CI 23%-36%, P=.001). Conclusion In this pilot study, CPAP significantly reduced lung tumor motion compared with free breathing. The smaller ITV, the planning target volume (PTV), and the increase in total lung volume associated with CPAP contributed to a reduction in lung and heart dose. CPAP was well tolerated, reproducible, and simple to implement in the treatment room and should be evaluated further as a novel strategy for motion management in radiation therapy.

Original languageEnglish
Pages (from-to)391-399
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume93
Issue number2
DOIs
StatePublished - 1 Oct 2015
Externally publishedYes

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Continuous positive airway pressure for motion management in stereotactic body radiation therapy to the lung: A controlled pilot study earlier versions of this work were accepted for presentation at the third ESTRO Forum, April 24-28, 2015, in Barcelona, Spain, and ISCORT, January 27-30, 2015, in Eilat, Israel.'. Together they form a unique fingerprint.

Cite this